Skip links

Our Coverage: Sorrento Therapeutics NASDAQ:SRNE

Sorrento Therapeutics, Inc. is a biopharmaceutical company. The Company researches human therapeutic antibodies for the treatment of cancer, inflammation, metabolic, and infectious diseases. VIEW ALL SORRENTO THERAPEUTICS REPORT DOWNLOADS